Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
CD25/IL-2R alpha Antibody (Basiliximab) - Chimeric - Azide and BSA Free, Novus Biologicals™

Human Monoclonal Antibody
Supplier: Novus Biologicals NBP275902SS
Description
CD25/IL-2R alpha Monoclonal specifically detects CD25/IL-2R alpha in Human, Cynomolgus Monkey, Rhesus Macaque samples. It is validated for Western Blot, Flow Cytometry, Immunohistochemistry, Immunofluorescence, Block/Neutralize.Specifications
CD25/IL-2R alpha | |
Monoclonal | |
Unconjugated | |
PBS with 0.02% Proclin 300 | |
IL2RA | |
Basiliximab was prepared by immunizing BALB/c mice with CTC 16 cells. | |
0.025 mg | |
3559.0 | |
Human, Cynomolgus Monkey, Rhesus Macaque | |
Purified |
Immunofluorescence, Flow Cytometry, Immunohistochemistry, Immunofluorescence, Blocking Assay, Neutralization | |
Basiliximab | |
Western Blot, Flow Cytometry, Immunohistochemistry, Immunofluorescence, Block/Neutralize | |
biosimilar, biosimilars, CD25, CD25 antigen, IDDM10, IL-2 receptor subunit alpha, IL2R, IL-2R subunit alpha, IL-2-RA, IL2-RA, interleukin 2 receptor, alpha, interleukin-2 receptor subunit alpha, p55, TAC antigen, TCGFR | |
Human | |
Protein A purified | |
Primary | |
Basiliximab recognises the human IL-2R and binds to the epitope (116)ERIYHFV(122) within the extracellular domain of the CD25 subunit -binding is abolished when 2 or more residues within the epitope are mutated. This epitope overlaps with the interaction site of CD25 and IL-2. CD25 is found in the high-affinity IL-2R ((alpha)(beta)(gamma)c) -T cells only express CD25 upon activation. IL-2 binding to IL-2R on T cells modulates proliferation and differentiation. | |
Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C. | |
IgG1 κ |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction